Researchers in the United Kingdom, Canada and Sweden are taking part in a study to ascertain whether the use of BlackBerries to transmit real-time health information can boost the treatment of patients with chronic conditions.
Where are the most high-tech start-ups? That`s an easy one: Silicon Valley. But who comes in a close second? Surprisingly: Israel. Further: Israel ranks Number 1 in terms of availability of scientists and engineers and Number 2 in quality of higher education. The result of this impressive track record is a wide range of successful enterprises and products, particularly related to the life…
Faced with meniscus injuries surgeons usually decide to remove the torn meniscal cartilage, which typically leaves the deficient knee vulnerable to future arthritis, because the padding that provides shock absorption and joint stability has been removed, causing bone to rub on bone.
The Acuson P10 - barely bigger than your BlackBerry and weighing just 500 grams.
IVAM is an international association of companies and institutes that specialise in microtechnology, nanotechnology and advanced materials.
Germany - Rather than the time consuming procedure of suturing a wound, Epiglu simply needs adapting to size then application.
Micro and medical technology are growing together and driving one another on to new developments. According to a survey by IVAM, the Professional Association for Microtechnology (Dortmund), medical technology is the principal target sector for European microtechnology companies, with a clear lead on the telecommunication and electronic industries.
As in past years, this year's MEDICA is one of the most important stages for the medical technology industry. International manufacturers will do a song and dance to dazzle the international clientele. As Managing Director of the German Electrical and Electronic Manufacturers' Association (Deutscher Zentralverband Elektrotechnik- und Elektronikindustrie e.V. - ZVEI), Hans-Peter Bursig, is well…
As in past years, this year's MEDICA is one of the most important stages for the medical technology industry. International manufacturers will do a song and dance to dazzle the international clientele. As Managing Director of the German Electrical and Electronic Manufacturers' Association (Deutscher Zentralverband Elektrotechnik- und Elektronikindustrie e.V. - ZVEI), Hans-Peter Bursig, is well…
More than 200 healthcare IT providers integrate Philips SpeechMagic into their applications, including global leaders such as SIEMENS, GE Healthcare, AGFA, Carestream Health and Philips Medical Systems. It is the first time that Philips has invited its partners to Germany, following the company's increasing activities in that market.
BOWA is establishing itself as a complete supplier of medical technology; the firm provides equipment both for complex procedures and for standard operations, enabling hospitals to equip themselves its entire product range.
The Technology initiative “Molecular Imaging” aims to strengthen the synergies of science and industry in research and development of new technologies in order to significantly improve diagnostic and treatment options, for example for cardiovascular diseases, cancer or Alzheimer's.
Telematics appears to offer solutions for certain complex therapies - and for issues that will become central as populations further swell with age.
Provotec GmbH & Co. KG, based in Espelkamp, Germany, reports that its Prognost XPE table series is being sold in the USA and internationally.
Demanding design, sophisticated technique and constantly improved materials guarantee lasting osseo-integration, writes Norbert Kamps, consultant engineer for aid provision and medical technology in Germany
For 2 1/2 years we have had the opportunity to use a 64-MSCT in our emergency department at the Brüder-Krankenhaus Trier, the biggest institution of the Brothers of Charity and academic teaching hospital at the University of the State Capital of Mainz.
The first wireless POC (Point of care) blood glucose and bedside testing solution for hospitals was launched by Bayer Healthcare during the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Amsterdam this September.
A compact portable, easy-to-use ECG machine, the MAC 400, was launched in Europe by GE Healthcare at the recent European Society of Cardiology (ESC).
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
The US firm Boston Scientific reports that it has received the Conformité Européenne (CE) Mark for its Confient implantable cardioverter defibrillator (ICD), the company's first branded cardiac rhythm management device to treat sudden cardiac death. Containing wireless capability, the Confient ICD has been designed to reduce right ventricular pacing.
Visage PACS/CS, a scalable PACS solution based on web and thin client technology with fully integrated clinical applications, is to be demonstrated at this year's RSNA in Chicago, along with a comprehensive portfolio of life sciences products and services from Visage Imaging, a subsidiary of Mercury Computer Systems Inc.
According to a study from the technology consultancy Frost & Sullivan the market for CT systems in Europe will grow annually by 4% - in 2013 sales will be worth $1.14 billion. Customers' primary request are cardiac imaging applications, but software innovations and improvements in scan time and image acquisition are also distinguishing features of next-generation systems.
A new blood pressure (BP) measuring device that provides, along with all the conventional cardiovascular parameters, the cardiac stroke volume, peripheral resistance and arterial augmentation, has been developed at the Austrian Research Centre (ARC), Vienna-Seibersdorf. The result of seven years' work by researchers, the device, named CardioMon, is now ready for sale.
The Lifebridge B2T (bridge-to-transport) is the first, fully portable emergency life support system for patients suffering cardiogenic shock, or those showing signs of imminent cardiogenic shock.
Boston Scientific Corporation has commenced enrolment of a targeted 1,500 patients for the Taxus Perseus clinical trials, planned to take place in 100 international centres.
